Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases

Mark B. Faries,Nicola Mozzillo,Mohammed Kashani-Sabet,John F. Thompson,Mark C. Kelley,Ronald C. DeConti,Jeffrey E. Lee,James F. Huth,Jeffrey D. Wagner,Angus G. Dalgleish,Daniel Pertschuk,Christopher Nardo,Stacey L. Stern,Robert M. Elashoff,Guy Gammon,Donald L. Morton

Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases

2017

Mark B. Faries
Nicola Mozzillo
Mohammed Kashani-Sabet
John F. Thompson
Mark C. Kelley
Ronald C. DeConti
Jeffrey E. Lee
James F. Huth
Jeffrey D. Wagner
Angus G. Dalgleish
Daniel Pertschuk
Christopher Nardo
Stacey L. Stern
Robert M. Elashoff
Guy Gammon
Donald L. Morton

Background This phase III study was undertaken to evaluate the efficacy of an allogeneic whole-cell vaccine (Canvaxin™) plus bacillus Calmette-Guerin (BCG) after complete resection of stage IV melanoma.

Keywords:

Melanoma
General surgery
Adjuvant
Immunotherapy
Resection
Medicine
surgical resection
Internal medicine
Oncology
Surgery
Combined Modality Therapy
long term survival
Survival rate
Surgical oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations